Global Generic Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
January 2020
139
About the Report
About the Report
Summary
Market Overview
The global Generic Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.6% in the forecast period of 2020 to 2025 and will expected to reach USD 381720 million by 2025, from USD 264830 million in 2019.
The Generic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Generic Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Generic Drugs market has been segmented into Simple Generic Drugs, Super Generic Drugs, Biosimilars, etc.
By Application, Generic Drugs has been segmented into CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Respiratory, Rheumatology, Diabetes, Oncology, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Generic Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Generic Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Generic Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Generic Drugs market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Generic Drugs markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Generic Drugs Market Share Analysis
Generic Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Generic Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Generic Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Generic Drugs are: Teva, Sanofi, Sun Pharmaceutical, Novartis-Sandoz, Pfizer (Hospira), Mylan, Lupin, Fresenius Kabi, Aspen, Aurobindo, Stada Arzneimittel, Valeant, Dr. Reddy's, Hikma, Krka Group, ENDO (Par Pharmaceutical), Apotex, Zydus Cadila, Nichi-Iko Pharmaceutical, Cipla, etc. Among other players domestic and global, Generic Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Generic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Generic Drugs, with price, sales, revenue and global market share of Generic Drugs in 2018 and 2019.
Chapter 3, the Generic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Generic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Generic Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Generic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Products
Table of Contents
Table of Contents
Table of Contents
1 Market Overview
1.1 Generic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Generic Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Simple Generic Drugs
1.2.3 Super Generic Drugs
1.2.4 Biosimilars
1.3 Market Analysis by Application
1.3.1 Overview: Global Generic Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Overview of Global Generic Drugs Market
1.4.1 Global Generic Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva SWOT Analysis
2.1.4 Teva Product and Services
2.1.5 Teva Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sun Pharmaceutical
2.3.1 Sun Pharmaceutical Details
2.3.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sun Pharmaceutical SWOT Analysis
2.3.4 Sun Pharmaceutical Product and Services
2.3.5 Sun Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis-Sandoz
2.4.1 Novartis-Sandoz Details
2.4.2 Novartis-Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis-Sandoz SWOT Analysis
2.4.4 Novartis-Sandoz Product and Services
2.4.5 Novartis-Sandoz Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer (Hospira)
2.5.1 Pfizer (Hospira) Details
2.5.2 Pfizer (Hospira) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer (Hospira) SWOT Analysis
2.5.4 Pfizer (Hospira) Product and Services
2.5.5 Pfizer (Hospira) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Mylan SWOT Analysis
2.6.4 Mylan Product and Services
2.6.5 Mylan Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Lupin
2.7.1 Lupin Details
2.7.2 Lupin Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Lupin SWOT Analysis
2.7.4 Lupin Product and Services
2.7.5 Lupin Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Fresenius Kabi
2.8.1 Fresenius Kabi Details
2.8.2 Fresenius Kabi Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Fresenius Kabi SWOT Analysis
2.8.4 Fresenius Kabi Product and Services
2.8.5 Fresenius Kabi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Aspen
2.9.1 Aspen Details
2.9.2 Aspen Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Aspen SWOT Analysis
2.9.4 Aspen Product and Services
2.9.5 Aspen Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Aurobindo
2.10.1 Aurobindo Details
2.10.2 Aurobindo Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Aurobindo SWOT Analysis
2.10.4 Aurobindo Product and Services
2.10.5 Aurobindo Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Stada Arzneimittel
2.11.1 Stada Arzneimittel Details
2.11.2 Stada Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Stada Arzneimittel SWOT Analysis
2.11.4 Stada Arzneimittel Product and Services
2.11.5 Stada Arzneimittel Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Valeant
2.12.1 Valeant Details
2.12.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Valeant SWOT Analysis
2.12.4 Valeant Product and Services
2.12.5 Valeant Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Dr. Reddy's
2.13.1 Dr. Reddy's Details
2.13.2 Dr. Reddy's Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Dr. Reddy's SWOT Analysis
2.13.4 Dr. Reddy's Product and Services
2.13.5 Dr. Reddy's Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Hikma
2.14.1 Hikma Details
2.14.2 Hikma Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Hikma SWOT Analysis
2.14.4 Hikma Product and Services
2.14.5 Hikma Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Krka Group
2.15.1 Krka Group Details
2.15.2 Krka Group Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Krka Group SWOT Analysis
2.15.4 Krka Group Product and Services
2.15.5 Krka Group Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 ENDO (Par Pharmaceutical)
2.16.1 ENDO (Par Pharmaceutical) Details
2.16.2 ENDO (Par Pharmaceutical) Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 ENDO (Par Pharmaceutical) SWOT Analysis
2.16.4 ENDO (Par Pharmaceutical) Product and Services
2.16.5 ENDO (Par Pharmaceutical) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Apotex
2.17.1 Apotex Details
2.17.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Apotex SWOT Analysis
2.17.4 Apotex Product and Services
2.17.5 Apotex Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Zydus Cadila
2.18.1 Zydus Cadila Details
2.18.2 Zydus Cadila Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Zydus Cadila SWOT Analysis
2.18.4 Zydus Cadila Product and Services
2.18.5 Zydus Cadila Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Nichi-Iko Pharmaceutical
2.19.1 Nichi-Iko Pharmaceutical Details
2.19.2 Nichi-Iko Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Nichi-Iko Pharmaceutical SWOT Analysis
2.19.4 Nichi-Iko Pharmaceutical Product and Services
2.19.5 Nichi-Iko Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Cipla
2.20.1 Cipla Details
2.20.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Cipla SWOT Analysis
2.20.4 Cipla Product and Services
2.20.5 Cipla Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Generic Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Generic Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Generic Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Generic Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Generic Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Generic Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Generic Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Generic Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Generic Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Generic Drugs Sales and Growth Rate (2015-2020)
4.5 South America Generic Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Generic Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Generic Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Generic Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Generic Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Generic Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Generic Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Generic Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Generic Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Generic Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Generic Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Generic Drugs Sales and Growth Rate (2015-2020)
6.3 UK Generic Drugs Sales and Growth Rate (2015-2020)
6.4 France Generic Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Generic Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Generic Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Generic Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Generic Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Generic Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Generic Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Generic Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Generic Drugs Sales and Growth Rate (2015-2020)
7.5 India Generic Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Generic Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Generic Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Generic Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Generic Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Generic Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Generic Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Generic Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Generic Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Generic Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Generic Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Generic Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Generic Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Generic Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Generic Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Generic Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Generic Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Generic Drugs Price by Type (2015-2020)
11 Global Generic Drugs Market Segment by Application
11.1 Global Generic Drugs Sales Market Share by Application (2015-2020)
11.2 Global Generic Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Generic Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Generic Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Generic Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Generic Drugs Market Forecast (2021-2025)
12.2.2 Europe Generic Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Generic Drugs Market Forecast (2021-2025)
12.2.4 South America Generic Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Generic Drugs Market Forecast (2021-2025)
12.3 Generic Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Generic Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Generic Drugs Market Share Forecast by Type (2021-2025)
12.4 Generic Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Generic Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Generic Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
List of Figure
List of Tables
Table 1. Global Generic Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Generic Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Generic Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Generic Drugs Major Business
Table 9. Teva Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Teva SWOT Analysis
Table 11. Teva Generic Drugs Product and Services
Table 12. Teva Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Generic Drugs Major Business
Table 15. Sanofi Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Sanofi SWOT Analysis
Table 17. Sanofi Generic Drugs Product and Services
Table 18. Sanofi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Sun Pharmaceutical Generic Drugs Major Business
Table 21. Sun Pharmaceutical Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Sun Pharmaceutical SWOT Analysis
Table 23. Sun Pharmaceutical Generic Drugs Product and Services
Table 24. Sun Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis-Sandoz Basic Information, Manufacturing Base and Competitors
Table 26. Novartis-Sandoz Generic Drugs Major Business
Table 27. Novartis-Sandoz Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Novartis-Sandoz SWOT Analysis
Table 29. Novartis-Sandoz Generic Drugs Product and Services
Table 30. Novartis-Sandoz Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Pfizer (Hospira) Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer (Hospira) Generic Drugs Major Business
Table 33. Pfizer (Hospira) Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Pfizer (Hospira) SWOT Analysis
Table 35. Pfizer (Hospira) Generic Drugs Product and Services
Table 36. Pfizer (Hospira) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Mylan Basic Information, Manufacturing Base and Competitors
Table 38. Mylan Generic Drugs Major Business
Table 39. Mylan Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Mylan SWOT Analysis
Table 41. Mylan Generic Drugs Product and Services
Table 42. Mylan Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Lupin Basic Information, Manufacturing Base and Competitors
Table 44. Lupin Generic Drugs Major Business
Table 45. Lupin Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Lupin SWOT Analysis
Table 47. Lupin Generic Drugs Product and Services
Table 48. Lupin Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 50. Fresenius Kabi Generic Drugs Major Business
Table 51. Fresenius Kabi Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Fresenius Kabi SWOT Analysis
Table 53. Fresenius Kabi Generic Drugs Product and Services
Table 54. Fresenius Kabi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Aspen Basic Information, Manufacturing Base and Competitors
Table 56. Aspen Generic Drugs Major Business
Table 57. Aspen Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Aspen SWOT Analysis
Table 59. Aspen Generic Drugs Product and Services
Table 60. Aspen Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 62. Aurobindo Generic Drugs Major Business
Table 63. Aurobindo Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Aurobindo SWOT Analysis
Table 65. Aurobindo Generic Drugs Product and Services
Table 66. Aurobindo Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Stada Arzneimittel Basic Information, Manufacturing Base and Competitors
Table 68. Stada Arzneimittel Generic Drugs Major Business
Table 69. Stada Arzneimittel Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Stada Arzneimittel SWOT Analysis
Table 71. Stada Arzneimittel Generic Drugs Product and Services
Table 72. Stada Arzneimittel Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Valeant Basic Information, Manufacturing Base and Competitors
Table 74. Valeant Generic Drugs Major Business
Table 75. Valeant Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Valeant SWOT Analysis
Table 77. Valeant Generic Drugs Product and Services
Table 78. Valeant Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Dr. Reddy's Basic Information, Manufacturing Base and Competitors
Table 80. Dr. Reddy's Generic Drugs Major Business
Table 81. Dr. Reddy's Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Dr. Reddy's SWOT Analysis
Table 83. Dr. Reddy's Generic Drugs Product and Services
Table 84. Dr. Reddy's Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Hikma Basic Information, Manufacturing Base and Competitors
Table 86. Hikma Generic Drugs Major Business
Table 87. Hikma Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Hikma SWOT Analysis
Table 89. Hikma Generic Drugs Product and Services
Table 90. Hikma Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Krka Group Basic Information, Manufacturing Base and Competitors
Table 92. Krka Group Generic Drugs Major Business
Table 93. Krka Group Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 94. Krka Group SWOT Analysis
Table 95. Krka Group Generic Drugs Product and Services
Table 96. Krka Group Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. ENDO (Par Pharmaceutical) Basic Information, Manufacturing Base and Competitors
Table 98. ENDO (Par Pharmaceutical) Generic Drugs Major Business
Table 99. ENDO (Par Pharmaceutical) Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 100. ENDO (Par Pharmaceutical) SWOT Analysis
Table 101. ENDO (Par Pharmaceutical) Generic Drugs Product and Services
Table 102. ENDO (Par Pharmaceutical) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Apotex Basic Information, Manufacturing Base and Competitors
Table 104. Apotex Generic Drugs Major Business
Table 105. Apotex Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 106. Apotex SWOT Analysis
Table 107. Apotex Generic Drugs Product and Services
Table 108. Apotex Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Zydus Cadila Generic Drugs Type and Application
Table 110. Zydus Cadila Generic Drugs Major Business
Table 111. Zydus Cadila Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 112. Zydus Cadila SWOT Analysis
Table 113. Zydus Cadila Generic Drugs Product and Services
Table 114. Zydus Cadila Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Nichi-Iko Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Nichi-Iko Pharmaceutical Generic Drugs Major Business
Table 117. Nichi-Iko Pharmaceutical Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 118. Nichi-Iko Pharmaceutical SWOT Analysis
Table 119. Nichi-Iko Pharmaceutical Generic Drugs Product and Services
Table 120. Nichi-Iko Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Cipla Basic Information, Manufacturing Base and Competitors
Table 122. Cipla Generic Drugs Major Business
Table 123. Cipla Generic Drugs Total Revenue (USD Million) (2017-2018)
Table 124. Cipla SWOT Analysis
Table 125. Cipla Generic Drugs Product and Services
Table 126. Cipla Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Global Generic Drugs Sales by Manufacturer (2018-2019) (K MT)
Table 128. Global Generic Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 129. Global Generic Drugs Sales by Regions (2015-2020) (K MT)
Table 130. Global Generic Drugs Sales Market Share by Regions (2015-2020)
Table 131. Global Generic Drugs Revenue by Regions (2015-2020) (USD Million)
Table 132. North America Generic Drugs Sales by Countries (2015-2020) (K MT)
Table 133. North America Generic Drugs Sales Market Share by Countries (2015-2020)
Table 134. North America Generic Drugs Revenue by Countries (2015-2020) (USD Million)
Table 135. North America Generic Drugs Revenue Market Share by Countries (2015-2020)
Table 136. Europe Generic Drugs Sales by Countries (2015-2020) (K MT)
Table 137. Europe Generic Drugs Sales Market Share by Countries (2015-2020)
Table 138. Europe Generic Drugs Revenue by Countries (2015-2020) (USD Million)
Table 139. Asia-Pacific Generic Drugs Sales by Regions (2015-2020) (K MT)
Table 140. Asia-Pacific Generic Drugs Sales Market Share by Regions (2015-2020)
Table 141. Asia-Pacific Generic Drugs Revenue by Regions (2015-2020) (USD Million)
Table 142. South America Generic Drugs Sales by Countries (2015-2020) (K MT)
Table 143. South America Generic Drugs Sales Market Share by Countries (2015-2020)
Table 144. South America Generic Drugs Revenue by Countries (2015-2020) (USD Million)
Table 145. South America Generic Drugs Revenue Market Share by Countries (2015-2020)
Table 146. Middle East & Africa Generic Drugs Sales by Countries (2015-2020) (K MT)
Table 147. Middle East & Africa Generic Drugs Sales Market Share by Countries (2015-2020)
Table 148. Middle East & Africa Generic Drugs Revenue by Countries (2015-2020) (USD Million)
Table 149. Middle East & Africa Generic Drugs Revenue Market Share by Countries (2015-2020)
Table 150. Global Generic Drugs Sales by Type (2015-2020) (K MT)
Table 151. Global Generic Drugs Sales Share by Type (2015-2020)
Table 152. Global Generic Drugs Revenue by Type (2015-2020) (USD Million)
Table 153. Global Generic Drugs Revenue Share by Type (2015-2020)
Table 154. Global Generic Drugs Sales by Application (2015-2020) (K MT)
Table 155. Global Generic Drugs Sales Share by Application (2015-2020)
Table 156. Global Generic Drugs Sales Forecast by Regions (2021-2025) (K MT)
Table 157. Global Generic Drugs Market Share Forecast by Regions (2021-2025)
Table 158. Global Generic Drugs Sales Forecast by Type (2021-2025) (K MT)
Table 159. Global Generic Drugs Market Share Forecast by Type (2021-2025)
Table 160. Global Generic Drugs Sales Forecast by Application (2021-2025)
Table 161. Global Generic Drugs Market Share Forecast by Application (2021-2025)
Table 162. Direct Channel Pros & Cons
Table 163. Indirect Channel Pros & Cons
Table 164. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Generic Drugs Picture
Figure 2. Global Sales Market Share of Generic Drugs by Type in 2019
Figure 3. Simple Generic Drugs Picture
Figure 4. Super Generic Drugs Picture
Figure 5. Biosimilars Picture
Figure 6. Generic Drugs Sales Market Share by Application in 2018
Figure 7. CNS Picture
Figure 8. Cardiovascular Picture
Figure 9. Genitourinary/Hormonal Drugs Picture
Figure 10. Respiratory Picture
Figure 11. Rheumatology Picture
Figure 12. Diabetes Picture
Figure 13. Oncology Picture
Figure 14. Others Picture
Figure 15. Global Generic Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Generic Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Generic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Generic Drugs Sales Market Share by Manufacturer in 2019
Figure 36. Global Generic Drugs Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Generic Drugs Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Generic Drugs Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 41. Global Generic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Generic Drugs Revenue Market Share by Regions (2015-2020)
Figure 43. Global Generic Drugs Revenue Market Share by Regions in 2018
Figure 44. North America Generic Drugs Sales and Growth Rate (2015-2020)
Figure 45. Europe Generic Drugs Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Generic Drugs Sales and Growth Rate (2015-2020)
Figure 47. South America Generic Drugs Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Generic Drugs Sales and Growth Rate (2015-2020)
Figure 49. North America Generic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Generic Drugs Sales Market Share by Countries (2015-2020)
Figure 51. North America Generic Drugs Sales Market Share by Countries in 2018
Figure 52. North America Generic Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Generic Drugs Revenue Market Share by Countries in 2018
Figure 54. United States Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 55. Canada Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 56. Mexico Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Europe Generic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Generic Drugs Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Generic Drugs Revenue Market Share by Countries in 2019
Figure 60. Germany Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 61. UK Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 62. France Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Russia Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Italy Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Asia-Pacific Generic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Generic Drugs Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Generic Drugs Revenue Market Share by Regions 2019
Figure 68. China Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Japan Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Korea Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 71. India Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Southeast Asia Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 73. South America Generic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Generic Drugs Sales Market Share by Countries in 2019
Figure 75. South America Generic Drugs Revenue Market Share by Countries in 2019
Figure 76. Brazil Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Argentina Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Middle East and Africa Generic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Generic Drugs Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Generic Drugs Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Generic Drugs Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Egypt Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 84. Turkey Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 85. South Africa Generic Drugs Sales and Growth Rate (2015-2020) (K MT)
Figure 86. Global Generic Drugs Sales and Growth Rate (2021-2025) (K MT)
Figure 87. Global Generic Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Generic Drugs Market Forecast (2021-2025) (K MT)
Figure 89. Europe Sales Generic Drugs Market Forecast (2021-2025) (K MT)
Figure 90. Asia-Pacific Sales Generic Drugs Market Forecast (2021-2025) (K MT)
Figure 91. South America Sales Generic Drugs Market Forecast (2021-2025) (K MT)
Figure 92. Middle East & Africa Sales Generic Drugs Market Forecast (2021-2025) (K MT)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.